Læs den fulde meddelelse hos Globenewswire: Gå til Globenewswire
Medical Prognosis Institute A/S ("MPI") hereby announces that the company has sold its holdings in Oncology Venture Sweden AB ("Oncology Venture"). As part of the merger the combined company is not allowed to hold own shares and hence the Company has capitalized the shareholding. In total, MPI has sold 1,168,538 shares (of 8.45 percent) in Oncology Venture, which provides the company a total of approximately SEK 18.1 million. The transactions were done off market with thirteen parties at an average share price of SEK 15.73.